Hai Zhen Pharmaceutical (600267.SH) subsidiary passed the drug GMP compliance inspection.

Zhixin Financial News App, Haizheng Pharmaceutical Co., Ltd. (600267.SH) issued an announcement that recently, the company's wholly-owned subsidiary Haizheng Pharmaceutical NanTong Co., Ltd. (referred to as "Haizheng NanTong Company") received the "Drug GMP Compliance Inspection Notification" (Su Yao Jian Yao Sheng Notification [2025] 438) from the Jiangsu Province Drug Administration.